Novel Design of Peptides to Reverse the Anticoagulant Activities of Heparin and other Glycosaminoglycans
Novel Design of Peptides to Reverse the Anticoagulant Activities of Heparin and other Glycosaminoglycans
复制标题
逆转肝素和其他糖胺聚糖抗凝活性的肽的新颖设计
DOI:
10.1055/s-0037-1615609
复制
发表时间:
2001
影响因子:
6.7
通讯作者:
Josè Martinez
中科院分区:
文献类型:
--
作者:
B. Schick;J. Gradowski;J. S. San Antonio;Josè Martinez
Summary Patients undergoing anticoagulation with unfractionated heparin, low molecular weight heparin, or danaparoid may experience excess bleeding which requires reversal of the anticoagulant agent. Protamine is at present the only agent available for reversal of unfractionated heparin. Protamine is not effective in patients who have received low molecular weight heparin or danaparoid. We have developed a series of peptides based on consensus heparin binding sequences (Verrecchio et al., J Biol Chem 2000; 275: 7701-7707) that are capable of neutralizing the anti-thrombin activity of unfractionated heparin in vitro, the antifactor Xa activity of unfractionated heparin, Enoxaparin (Lovenox) and danaparoid (Orgaran) in vitro and the anti-Factor Xa activity of Enoxaparin in vivo in rats. These peptides may serve as alternatives for Protamine reversal of UFH and may be useful for neutralization of enoxaparin and danaparoid in humans.
DOI:
10.1006/abbi.1996.0448
发表时间:
1996
期刊:
Archives of biochemistry and biophysics.
影响因子:
--
作者:
Tyler-Cross,R;Sobel,M;McAdory,LE;Harris,RB
通讯作者:
Harris,RB
DOI:
10.1016/s0022-5223(98)70057-1
发表时间:
1998
期刊:
The Journal of thoracic and cardiovascular surgery
影响因子:
--
作者:
Gikakis,N;Rao,AK;Miyamoto,S;Gorman3rd,JH;Khan,MM;Anderson,HL;Hack,CE;Sun,L;Niewiarowski,S;Colman,RW;EdmundsJr,LH
通讯作者:
EdmundsJr,LH